From research grants, to exciting discoveries and treatment breakthroughs, read the latest research news from the Melanoma Institute Australia team as we work tirelessly towards our goal of zero deaths from melanoma.
Global breakthrough in stopping melanoma spreading around body
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
FDA approves new combination immunotherapy
Australian researchers and patients were critical to trialling this breakthrough new treatment for advanced melanoma patients.
MIA joins Sydney Health Partners
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
Skin surveillance saves lives from melanoma
New research shows routine skin checks by a health professional, plus checking your own skin, are vital in saving lives from melanoma.
A paradigm shift in melanoma treatment
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
Prof Georgina Long AO awarded AAHMS Medal
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”
MIA’s Annual Research Retreat 2021
The Retreat shared highlights from MIA-led research activities. Despite COVID research has continued unabated.
Successful trial of new immunotherapy treatment
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
Sharing knowledge of melanoma on global stage
As leaders in melanoma field, researchers from MIA shared their knowledge at 10th World Congress of Melanoma.
Better understanding of melanoma in liver
New research has shed light on why advanced melanoma that has spread to the liver is particularly resistant to immunotherapy.
DNA changes drive progression of melanoma
The discovery of dramatic genetic changes may be key to developing new melanoma treatments.